[7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
D001161:Arteriosclerosis; D001162:Arteriosclerosis Obliterans; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease; D006801:Humans; D002537:Intracranial Arteriosclerosis; D050356:Lipid Metabolism; D009243:NAD; D009525:Niacin; D009539:Nicotinic Acids; D010600:Pharmacology; D013806:Theophylline; D014116:Toxicology; D014652:Vascular Diseases; D014665:Vasodilator Agents; D014666:Vasomotor System; D019820:Xanthine
D009539:Nicotinic Acids; D014665:Vasodilator Agents; D009243:NAD; D019820:Xanthine; D009525:Niacin; D002784:Cholesterol; D013806:Theophylline
ARTERIOSCLEROSIS; ARTERIOSCLEROSIS OBLITERANS; BLOOD CHOLESTEROL; CEREBRAL ARTERIOSCLEROSIS; CORONARY DISEASE; LIPID METABOLISM; NAD; NICOTINIC ACID; PHARMACOLOGY; THEOPHYLLINE; TOXICOLOGIC REPORT; VASCULAR DISEASES; VASODILATOR AGENTS; VASOMOTOR SYSTEM
EL NICOTINATO DE 7-